VIDI


The Vaccine and Infectious Disease Institute, VIDI, was established by the Fred Hutchinson Cancer Research Center in 2007 to address the growing need for treatment and prevention strategies for infectious diseases worldwide.  By integrating biometric, laboratory, and clinical science, the researchers at VIDI aim to develop novel vaccines for infectious diseases that threaten global health, to shed light on the workings of the human immune system, and to develop novel treatment and prevention strategies to lessen the burden of infectious diseases and cancers caused by infection, particularly in the immunocompromised host. 

VIDI is composed of three research groups: Population Sciences, including the Statistical Center for HIV and AIDS Research and Prevention (SCHARP), led by Dr. Steve Self; Infectious Disease Sciences, including HIV Vaccine Trials Network (HVTN), led by Dr. Larry Corey; and Immunology and Vaccine Development, led by Dr. Julie McElrath.

VIDI’s 23 faculty members also hold appointments in either the Clinical Research or Public Health Sciences Division at the Center.  VIDI also includes 18 affiliate investigators, mainly from the University of Washington.

For more, see About VIDI

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.

CenterNetCheck E-mail